This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Burd, E. M. Search for Related Content PubMed PubMed Citation Articles by Burd, E. M.

Next Article 

Clinical Microbiology Reviews, January 2003, p. 1-17, Vol. 16, No. 1
0893-8512/03/$08.00+0     DOI: 10.1128/CMR.16.1.1-17.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Human Papillomavirus and Cervical Cancer

Henry Ford Hospital, Detroit, Michigan

Of the many types of human papillomavirus (HPV), more than 30 infect the genital tract. The association between certain oncogenic (high-risk) strains of HPV and cervical cancer is well established. Although HPV is essential to the transformation of cervical epithelial cells, it is not sufficient, and a variety of cofactors and molecular events influence whether cervical cancer will develop. Early detection and treatment of precancerous lesions can prevent progression to cervical cancer. Identification of precancerous lesions has been primarily by cytologic screening of cervical cells. Cellular abnormalities, however, may be missed or may not be sufficiently distinct, and a portion of patients with borderline or mildly dyskaryotic cytomorphology will have higher-grade disease identified by subsequent colposcopy and biopsy. Sensitive and specific molecular techniques that detect HPV DNA and distinguish high-risk HPV types from low-risk HPV types have been introduced as an adjunct to cytology. Earlier detection of high-risk HPV types may improve triage, treatment, and follow-up in infected patients. Currently, the clearest role for HPV DNA testing is to improve diagnostic accuracy and limit unnecessary colposcopy in patients with borderline or mildly abnormal cytologic test results.

This article has been cited by other articles:

• Koshiol, J., Lindsay, L., Pimenta, J. M., Poole, C., Jenkins, D., Smith, J. S. (2008). Persistent Human Papillomavirus Infection and Cervical Neoplasia: A Systematic Review and Meta-Analysis. Am J Epidemiol 168: 123-137 [Abstract] [Full Text]  
• Nishiwaki, M., Yamamoto, T., Tone, S., Murai, T., Ohkawara, T., Matsunami, T., Koizumi, M., Takagi, Y., Yamaguchi, J., Kondo, N., Nishihira, J., Horikawa, T., Yoshiki, T. (2008). Genotyping of Human Papillomaviruses by a Novel One-Step Typing Method with Multiplex PCR and Clinical Applications. J. Clin. Microbiol. 46: 1161-1168 [Abstract] [Full Text]  
• Sroller, V., Vilchez, R. A., Stewart, A. R., Wong, C., Butel, J. S. (2008). Influence of the Viral Regulatory Region on Tumor Induction by Simian Virus 40 in Hamsters. J. Virol. 82: 871-879 [Abstract] [Full Text]  
• Brisson, M. PhD, Van de Velde, N. MSc, De Wals, P. MD PhD, Boily, M.-C. PhD (2007). Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection. CMAJ 177: 464-468 [Abstract] [Full Text]  
• Chernesky, M., Freund, G. G., Hook, E. III, Leone, P., D'Ascoli, P., Martens, M. (2007). Detection of Chlamydia trachomatis and Neisseria gonorrhoeae Infections in North American Women by Testing SurePath Liquid-Based Pap Specimens in APTIMA Assays. J. Clin. Microbiol. 45: 2434-2438 [Abstract] [Full Text]  
• Pyeon, D., Newton, M. A., Lambert, P. F., den Boon, J. A., Sengupta, S., Marsit, C. J., Woodworth, C. D., Connor, J. P., Haugen, T. H., Smith, E. M., Kelsey, K. T., Turek, L. P., Ahlquist, P. (2007). Fundamental Differences in Cell Cycle Deregulation in Human Papillomavirus-Positive and Human Papillomavirus-Negative Head/Neck and Cervical Cancers. Cancer Res. 67: 4605-4619 [Abstract] [Full Text]  
• Van de Velde, N., Brisson, M., Boily, M.-C. (2007). Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter Uncertainty. Am J Epidemiol 165: 762-775 [Abstract] [Full Text]  
• Fontaine, V., Mascaux, C., Weyn, C., Bernis, A., Celio, N., Lefevre, P., Kaufman, L., Garbar, C. (2007). Evaluation of Combined General Primer-Mediated PCR Sequencing and Type-Specific PCR Strategies for Determination of Human Papillomavirus Genotypes in Cervical Cell Specimens. J. Clin. Microbiol. 45: 928-934 [Abstract] [Full Text]  
• Shew, M. L., Fortenberry, J. D., Tu, W., Juliar, B. E., Batteiger, B. E., Qadadri, B., Brown, D. R. (2006). Association of Condom Use, Sexual Behaviors, and Sexually Transmitted Infections With the Duration of Genital Human Papillomavirus Infection Among Adolescent Women. Arch Pediatr Adolesc Med 160: 151-156 [Abstract] [Full Text]  
• Liu, X., Clements, A., Zhao, K., Marmorstein, R. (2006). Structure of the Human Papillomavirus E7 Oncoprotein and Its Mechanism for Inactivation of the Retinoblastoma Tumor Suppressor. J. Biol. Chem. 281: 578-586 [Abstract] [Full Text]  
• Pyeon, D., Lambert, P. F., Ahlquist, P. (2005). Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc. Natl. Acad. Sci. USA 102: 9311-9316 [Abstract] [Full Text]  
• Yang, H., Yang, K., Khafagi, A., Tang, Y., Carey, T. E., Opipari, A. W., Lieberman, R., Oeth, P. A., Lancaster, W., Klinger, H. P., Kaseb, A. O., Metwally, A., Khaled, H., Kurnit, D. M. (2005). Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc. Natl. Acad. Sci. USA 102: 7683-7688 [Abstract] [Full Text]  
• Magal, S. S., Jackman, A., Ish-Shalom, S., Botzer, L. E., Gonen, P., Schlegel, R., Sherman, L. (2005). Downregulation of Bax mRNA expression and protein stability by the E6 protein of human papillomavirus 16. J. Gen. Virol. 86: 611-621 [Abstract] [Full Text]  
• Verch, T., Pan, Z.-K., Paterson, Y. (2004). Listeria monocytogenes-Based Antibiotic Resistance Gene-Free Antigen Delivery System Applicable to Other Bacterial Vectors and DNA Vaccines. Infect. Immun. 72: 6418-6425 [Abstract] [Full Text]  
• Biedermann, K., Dandachi, N., Trattner, M., Vogl, G., Doppelmayr, H., More, E., Staudach, A., Dietze, O., Hauser-Kronberger, C. (2004). Comparison of Real-Time PCR Signal-Amplified In Situ Hybridization and Conventional PCR for Detection and Quantification of Human Papillomavirus in Archival Cervical Cancer Tissue. J. Clin. Microbiol. 42: 3758-3765 [Abstract] [Full Text]  
• Giovannelli, L., Lama, A., Capra, G., Giordano, V., Arico, P., Ammatuna, P. (2004). Detection of Human Papillomavirus DNA in Cervical Samples: Analysis of the New PGMY-PCR Compared To the Hybrid Capture II and MY-PCR Assays and a Two-Step Nested PCR Assay. J. Clin. Microbiol. 42: 3861-3864 [Abstract] [Full Text]  
• Autran, B., Carcelain, G., Combadiere, B., Debre, P. (2004). Therapeutic Vaccines for Chronic Infections. Science 305: 205-208 [Abstract] [Full Text]